<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title41.html">
                                    Title 41
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/41CFR101-42.html">Part 101-42
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 101-42.1102-3  Controlled substances.
                            </h3>
                            <p class="depth1"><em>(a)</em> Utilization requirements. (1) Excess controlled substances are not required to be reported to GSA, but are subject to the utilization screening requirements of Sec. 101-43.311-2. Holding agencies shall make reasonable efforts to obtain utilization of excess controlled substances by offering them to those Federal agencies which certify that they are registered with the Drug Enforcement Administration (DEA), Department of Justice, and are authorized to procure the particular controlled substances requested for transfer. The certification shall include the registration number on the DEA Form 223, Certificate of Registration, issued by DEA.</p><p class="depth2"><em>(1)</em> Excess controlled substances are not required to be reported to GSA, but are subject to the utilization screening requirements of Sec. 101-43.311-2. Holding agencies shall make reasonable efforts to obtain utilization of excess controlled substances by offering them to those Federal agencies which certify that they are registered with the Drug Enforcement Administration (DEA), Department of Justice, and are authorized to procure the particular controlled substances requested for transfer. The certification shall include the registration number on the DEA Form 223, Certificate of Registration, issued by DEA.</p><p class="depth2"><em>(2)</em> Holding agencies shall arrange for transfers of controlled substances under Sec. Sec. 101-43.309-5 and 101-42.207.</p><p class="depth2"><em>(3)</em> All controlled substances that a holding agency determines to be excess shall become surplus after the holding agency has complied with the utilization requirements of paragraph (a)(1) of this section.</p><p class="depth1"><em>(b)</em> Donation requirements. Controlled substances shall not be donated.</p><p class="depth1"><em>(c)</em> Sales requirements. Surplus controlled substances which are not required to be destroyed as provided in paragraph (d) of this section may be offered for sale by sealed bid under subpart 101-45.3 provided:</p><p class="depth2"><em>(1)</em> The invitation for bids (IFB):</p><p class="depth3"><em>(i)</em> Consists only of surplus controlled substances;</p><p class="depth3"><em>(ii)</em> Requires the normal bid deposit prescribed in Sec. 101-45.304-10;</p><p class="depth3"><em>(iii)</em> Is distributed only to bidders who are registered with the DEA, Department of Justice, to manufacture, distribute, or dispense the controlled substances for which the bid is being submitted; and</p><p class="depth3"><em>(iv)</em> Contains the following special condition of sale:</p><p class="depth4">The bidder shall complete, sign, and return with his/her bid the certificate as contained in this invitation. No award will be made or sale consummated until after this agency has obtained from the Drug Enforcement Administration, Department of Justice, verification that the bidder is registered to manufacture, distribute, or dispense those

controlled substances which are the subject of the award.</p><p class="depth2"><em>(2)</em> The following certification shall be made a part of the IFB (and contract) to be completed and signed by the bidder and returned with the bid:</p><p class="depth3">The bidder certifies that he/she is registered with the Drug Enforcement Administration, Department of Justice, as a manufacturer, distributor, or dispenser of the controlled substances for which a bid is submitted and that the registration number is ____.________________________________________________________________________Name of bidder (print or type)________________________________________________________________________Signature of bidder________________________________________________________________________Address of bidder (print or type)________________________________________________________________________City, State, Zip code</p><p class="depth2"><em>(3)</em> As a condition precedent to making an award for surplus controlled substances, the following shall be submitted to the Drug Enforcement Administration (DEA), Department of Justice, Washington, DC 20537, Attn: Regulatory Support Section (ODR):</p><p class="depth3"><em>(i)</em> The name and address of the bidder(s) to whom an award is proposed to be made and the bidder(s) registration number(s);</p><p class="depth3"><em>(ii)</em> The name and address of both the holding activity and the selling activity;</p><p class="depth3"><em>(iii)</em> A description of the controlled substances, how those substances are packaged, and the quantity of substances proposed to be sold to the bidder;</p><p class="depth3"><em>(iv)</em> The identification of the IFB by its number, and date on which such bid(s) expire(s); and</p><p class="depth3"><em>(v)</em> A request for advice as to whether the bidder is a registered manufacturer, distributor, or dispenser of controlled substances.</p><p class="depth1"><em>(d)</em> Destruction of controlled substances. Controlled substances shall not be abandoned, and destruction of controlled substances must be accomplished in accordance with the terms and conditions applicable to drugs, biologicals, and reagents under Sec. 101-42.1102-5(d).</p><p class="depth2"><em>(1)</em> The following shall be destroyed by the holding agency or State agency:</p><p class="depth3"><em>(i)</em> Controlled substances determined surplus at one time and one place with an acquisition cost of less than $500;</p><p class="depth3"><em>(ii)</em> Controlled substances in a deteriorated condition or otherwise unusable;</p><p class="depth3"><em>(iii)</em> Controlled substances for sale in accordance with Sec. 101-42.1102-3(c) but for which no satisfactory or acceptable bids were received.</p><p class="depth2"><em>(2)</em> In addition to the requirements set forth herein, each executive agency and State agency shall comply with the DEA regulations, 21 CFR 1307.21, which provide procedures for disposing of controlled substances, or with equivalent procedures approved by DEA.</p><p class="depth2"><em>(3)</em> Destruction of controlled substances shall be performed by an employee of the holding agency or State agency in the presence of two additional employees of the agency as witnesses to that destruction unless the special agent in charge (SAC) of the DEA Divisional Office directs otherwise.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
